Related Experiment Video
Updated: Jun 6, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Carbon monoxide-releasing micelles for immunotherapy
Urara Hasegawa1, André J van der Vlies, Eleonora Simeoni
1Institute of Bioengineering (IBI), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne CH-1015, Switzerland.
This study developed novel CO-releasing micelles for improved carbon monoxide (CO) therapy. These micelles offer controlled CO release and reduced toxicity, showing potential for therapeutic applications.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Background:
- Carbon monoxide (CO) has important biological roles, but its therapeutic use is limited by administration challenges.
- Existing CO-releasing molecules (CORMs) like transition-metal carbonyl complexes face hurdles in targeted delivery and controlled release.
- Developing advanced drug delivery systems is crucial for harnessing CO's therapeutic potential.
Purpose of the Study:
- To engineer a novel CO-delivery system using polymeric micelles incorporating a ruthenium carbonyl complex.
- To create micellar CO-releasing agents with enhanced tissue diffusion control and targeted delivery capabilities.
- To evaluate the efficacy, safety, and release kinetics of these novel CO-releasing micelles.
Main Methods:
- Synthesis of triblock copolymers containing hydrophilic PEG, poly(ornithine acrylamide) with Ru(CO)(3)Cl(ornithinate), and hydrophobic poly(n-butylacrylamide) blocks.
- Formation and characterization of spherical micelles (30-40 nm hydrodynamic diameter) with high CO-loading capacity.
- In vitro assessment of CO release kinetics in physiological conditions, evaluation of anti-inflammatory effects (NF-κB inhibition), and cytotoxicity studies.
Main Results:
- The developed micelles exhibited controlled and sustained CO release, slower than conventional Ru(CO)(3)Cl(glycinate).
- Micelles demonstrated significant attenuation of lipopolysaccharide-induced NF-κB activation in human monocytes, unlike the non-micellar complex.
- Cytotoxicity assays confirmed that the micellar formulation significantly reduced the inherent toxicity of the Ru(CO)(3)Cl(amino acidate) moiety.
Conclusions:
- Novel CO-releasing micelles based on a Ru(CO)(3)Cl(amino acidate) structure were successfully developed.
- This micellar system provides a promising platform for controlled CO delivery, enhancing therapeutic efficacy and safety.
- The findings suggest potential applications of these CO-releasing micelles in various therapeutic contexts.
More Related Videos
07:32Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015